Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02575339
Title MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bert O'Neil, MD
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Sapanisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Noth Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field